About GIOSTAR – USA

 

Regenerative medicine has been called the “next evolution of medical treatments,” by the U.S. Department of Health and Human Services. “With its potential to heal, this new field of science is expected to revolutionize health care.”

Global Institute of Stem Cell Therapy and Research (GIOSTAR), headquartered in San Diego, California (U.S.A.), was formed with the vision to provide stem cell based therapy to aid those suffering from degenerative or genetic diseases around the world.

GIOSTAR is one the first organizations in the world to get US FDA approval in April 2020 to treat COVID-19 patients with its proprietary stem cells treatment under FDA Compassionate Use Program: See following two new video coverage by ABC NEWS Channel 10 San Diego.

 

Endorsed by governments and health agencies around the world, GIOSTAR is the pioneering and leading stem cell research institute involved in discovering potential cures and treatments for degenerative diseases.

GIOSTAR’s science is the culmination of 20 years of groundbreaking research and private/public investments is the Gold Standard for the industry. It is developing noninvasive solutions for serious diseases and delivering hope. Headquartered in San Diego, led by Dr. Anand Srivastava, M.S., Ph.D., Chairman, Co-Founder and CSO and Deven Patel, President, CEO and Co-Founder.

GIOSTAR is in the process of opening Institutes of Regenerative Medicine in Asia, Middle East, Africa, North and South America and Europe. The proposed facilities will be developed with the international support from public and private sectors grants and investments to provide stem cell based therapy for those suffering from degenerative or genetic diseases.

GIOSTAR is a coalition of esteemed and illustrious scientific minds in the field of stem cell science, genetics and cancer research. For over 20 years the GIOSTAR team of scientists and clinicians have been involved in the development and utilization of stem cell-based protocols related to stem cell transplants.